Navigation Links
Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation
Date:6/19/2013

SANTA CLARA, Calif., June 19, 2013 /PRNewswire/ -- Finesse Solutions, Inc, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new SmartGlass™ autoclavable 3L glass bioreactors for upstream cell culture and fermentation.  The 3L glass vessels are the first in a new product family of Finesse bioreactors and are designed to optimize yield in both R&D and cGMP applications.  They are fully compatible with all Finesse G3Lab controllers, and with SmartAdapters can be utilized with third party controllers.

Designed for R&D and process development scale-up, SmartGlass vessels enable easier handling and faster assembly/disassembly for cleaning.  They were developed to be fully hygienic to ensure complete process sterility and minimize lost batches.  The vessels are manufactured with the highest standards for surface finish and safety of operation.

"We have made many design improvements to optimize the SmartGlass platform for cell culture and fermentation processes.  For examples, our cold finger has increased surface area to enable faster thermal control and increase cooling capacity so that a single-wall vessel can be used for fermentation.  We have also collaborated closely with the group of Profs. Dieter and Regine Eibl at the University of Wadenswil in Zurich, Switzerland, in order to create a novel impeller design that produces higher average kLa, and increases power transfer while minimizing shear. The vessels have been designed using all of the machinery available for computational fluid mechanics simulations," stated Dr. Mark Selker, Vice President of R&D and co-founder of Finesse Solutions.

About Finesse Solutions, Inc
California-based Finesse Solutions, Inc has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing.  The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer.  Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications. For more information, please visit us at www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, Inc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
2. Finesse Solutions Launches Next Generation G3Lab Universal SmartControllers to Enhance Productivity in Bench Scale Cell Culture and Fermentation
3. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
4. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
5. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
6. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
7. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
8. Ablative Solutions Completes $5.3M Series A Financing
9. DATATRAK Expands CDISC Registered Solutions Provider Standards
10. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
11. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... August 22, 2017 , ... Although Labor Day is ... many communities have begun providing weekend displays, and numerous households celebrate the unofficial end ... can be downright terrifying for pets. , Kris Zambo, owner of Dynamite ...
(Date:8/21/2017)... ... August 22, 2017 , ... Nanoparticle research provides ... and safety. By learning and implementing best practices for containment using ventilated safety ... attendees will gain a better understanding of a method for safely testing nanotechnology ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los Angeles area medical group ... academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, M.D. This one ... and Reconstructive Surgery. The candidate will have the opportunity to work with ...
(Date:8/21/2017)... ... August 21, 2017 , ... SportsEngine, Inc. , a ... Technology Partner of North Country Region Volleyball and will power registration, scheduling, and ... with providing sport management software to their member clubs. , SportsEngine ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... place all over the country. , Outdoor running increases exposure to ultraviolet radiation, ... an increased risk of melanoma, and only half may be adequately protecting themselves ...
Breaking Medicine News(10 mins):